All News

Jon Easter, RPh, discusses pharmacists’ ability to improve patient engagement in diabetes care following his presentation at the American Diabetes Association’s 85th Scientific Sessions.

Jon Easter, RPh, joined Drug Topics to discuss pharmacists’ roles within health care teams following his presentation at the American Diabetes Association’s 85th Scientific Sessions.

Nathan Ramsbacher, PharmD, emphasizes that one of the most significant barriers to clinical quality is patients' inability to access crucial medications due to cost.

The initiative focuses on managing medications for high-risk diabetes patients through a collaborative drug therapy agreement.

Taylor Watterson, PharmD, PhD, discusses how distress experienced by pharmacy technicians can impact the overall safety and quality of pharmacy operations.

Pharmaceutical Strategies Group experts joined Drug Topics to discuss the role GLP-1s play in drug benefit design.

Nicole Cieri-Hutcherson, PharmD, BCPS, MSCP, FCCP, discusses how pharmacists can support patient counseling and education around medication abortion.

At the Total Pharmacy Solutions Summit Summer 2025 event, Stephanie Zimmerman, Tom Napolitano, and Luke Gunderson discussed the benefits of Real Value RX.

Kevin Cleveland, PharmD, discusses how pharmacists are uniquely positioned to directly interact with patients, making them vital in addressing vaccine misinformation.

Heidi Polek, RPh, EMBA, discusses how pharmacies must adopt strategic approaches to maintain financial health and continue providing patient care.

Emily Endres, BSPS, and Todd Sega, PharmD, MBA, discuss pressures that pharmacies are currently facing, including reimbursements, competition, and patient needs.

Nicole Cieri-Hutcherson, PharmD, BCPS, MSCP, FCCP, discusses how pharmacist involvement in medication abortion can improve reproductive health care access.

John Hill, MBAHCM, and Pooja Babbrah, MBA, from the National Council for Prescription Drug Programs, discuss their organization’s strategic plan for advancing the pharmacy profession.

Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, from the Pharmaceutical Strategies Group, discuss the 2025 Trends in Drug Benefit Design Report and how it will impact pharmacists.

Laura Knockel, PharmD, BCACP, expresses concerns about how vaccine recommendations are being communicated, noting a shift away from traditional, transparent discussions to less formal channels such as social media.

Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, highlights the critical role pharmacists play in navigating vaccine recommendations and supporting patient understanding.

Deanna Tran, PharmD, BCACP, FAPhA, emphasizes community outreach, especially in areas with high vaccine hesitancy, as a crucial strategy for maintaining public trust in vaccination programs.

Pharmacists stress that rebuilding trust is challenging and requires careful, empathetic communication.

Taylor Watterson, PharmD, PhD, discusses what a truly inclusive and technician-centered pharmacy looks like and what it takes to get there.

Taylor Watterson, PharmD, PhD, discusses how to recognize the contribution of pharmacy technicians in day-to-day operations.

Independent pharmacy owner and educator Amina Abubakar, PharmD, AAHIVP, shares her hopes for the future of the pharmacy industry and advice for the next generation of pharmacists.

A conversation with Taylor Watterson, PharmD, PhD, assistant professor at the University of Chicago Illinois Retzky College of Pharmacy.

Owner of Avant Pharmacy, and President of the Avant Institute of Clinical Pharmacy, Amina Abubakar, PharmD, AAHIVP, discusses how her work in the industry is reaching far beyond the pharmacy counter.

Lauren Angelo, PharmD, MBA, associate dean of academic affairs at Rosalind Franklin University of Medicine and Science, highlights significant concerns about the evolving landscape of COVID-19 vaccine policy.

Lauren Angelo, PharmD, MBA, associate dean of academic affairs at Rosalind Franklin University of Medicine and Science, discusses the changing recommendations for COVID-19 vaccination.

Joey Mattingly, PharmD, MBA, PhD, and Marta Wosinska, PhD, discussed what pharmacy businesses can do to prepare for the potential implementation of tariffs on pharmaceutical products.

Drug Topics was joined by Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, to discuss the potential impact tariffs may have if they are widely implemented within the pharmaceutical industry.

Alecia Lashier, chief automation officer and executive vice president at iA, discusses transformations in the pharmacy industry and how they’ve impacted pharmacists and their businesses.